Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Quallion is a specialized manufacturer of high-performance lithium-ion batteries designed for the medical, aerospace, and defense sectors. The company is particularly recognized for its expertise in developing miniaturized, implantable power sources for life-critical medical devices, including neurostimulators, cardiac pacemakers, and cochlear implants. A key technological differentiator is Quallion's proprietary Zero-Volt technology, which enables batteries to be fully discharged to zero volts and stored without losing capacity or safety performance. Founded by renowned entrepreneur Alfred Mann, the company provides end-to-end services from custom cell design to large-scale manufacturing. In 2013, Quallion was acquired by EnerSys, a global leader in stored energy solutions, where it continues to operate as a center of excellence for medical and specialty battery applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Quallion.